UnknownNot Applicable

Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis

Thailand880 participantsStarted 2016-05-02

Plain-language summary

Peritoneal Dialysis (PD) has been the main method of treatment for Thai End-Stage Renal Disease (ESRD) patients under the "PD First" policy of the Universal Coverage (UC) scheme. The increased demand has resulted in not only supply chain logistical problems, but also product quality concerns. Peritonitis, the main complication and checklist cause of failure in Continuous Ambulatory Peritoneal Dialysis (CAPD) patients, could be caused by a product defect. This cluster randomized trial will be conducted in 22 randomly selected PD centers in Thailand to assess if a checklist intervention could reduce peritonitis rate and increase the number of checklist product defect report.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ESRD patients who start peritoneal dialysis not longer than one month and participate in PDOPPS study Exclusion Criteria: * ESRD patients who receive only hemodialysis * ESRD patients who receive emergency peritoneal dialysis * Illiterate ESRD patients or their caregivers

What they're measuring

Peritonitis Incidence Rate

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT02755610

SponsorChulalongkorn University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05

View on ClinicalTrials.gov More End-Stage Kidney Disease trials